Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Small Cell Lung Carcinoma 1Head and Neck Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Tobacco Use Cessation Devices 5Counseling 5Early Intervention, Educational 3Bupropion 3Varenicline 2Nicotine Replacement Therapy 2Nicotine 2Community Health Workers 2Aspirin 2zileuton 1phenethyl isothiocyanate 1phenanthrene tetraol 1phenanthrene 1Zinc Oxide 1Sulindac 1Risk Factors 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Methods 1Memantine 1Gene Expression Profiling 1Fertility 1Ethanol 1Drug Therapy 1Celecoxib 1Calcitriol 14-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tobacco Use Disorder × zileuton × Clear all
NCT01021215 2015-04-02

Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers

National Cancer Institute (NCI)

Phase 1/2 Completed
84 enrolled 10 charts

Smoking, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡